Research / MDLZ / Fundamental state Inspectable configuration
State dimensions Filing 0001103982-21-000004 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
64.99% · OPTIONAL · VALID
Capex intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.25% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.91% · OPTIONAL · VALID
Revenue growth 90th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
2.76% · CORE · VALID
Inventory pressure 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
9.96% · OPTIONAL · VALID
Gross margin 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
39.30% · CORE · VALID
Operating margin 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
14.50% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.25% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.47% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 39 states Self-history eligible
Mar 31, 2019 8/8 normalized Level 3 Jun 30, 2019 8/8 normalized Level 3 Sep 30, 2019 8/8 normalized Level 3 Dec 31, 2019 8/9 normalized Level 3 Mar 31, 2020 8/8 normalized Level 3 Jun 30, 2020 8/8 normalized Level 3 Sep 30, 2020 8/8 normalized Level 3 Dec 31, 2020 8/9 normalized Level 3 Mar 31, 2021 8/8 normalized Level 3 Jun 30, 2021 8/8 normalized Level 3 Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/9 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Sep 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 283.81%
Current 64.99%
Delta -218.82% Capex Intensity Increased
Previous 2.78%
Current 3.25%
Delta 0.47% Cash Generation Increased
Previous 11.36%
Current 14.91%
Delta 3.56% Growth Decreased
Previous 4.88%
Current 2.76%
Delta -2.12% Inventory Pressure Decreased
Previous 42.61%
Current 9.96%
Delta -32.65% Margin Decreased
Previous 41.89%
Current 39.30%
Delta -2.59% Profitability Decreased
Previous 17.03%
Current 14.50%
Delta -2.53% Sbc Intensity Decreased
Previous 0.51%
Current 0.47%
Delta -0.04% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.